← FDA DRUG APPROVALS

FDA ANDA · ANDA200918

ZOLEDRONIC ACID

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA200918
TYPE
ANDA
ORIGINAL APPROVAL
2014-08-21
LATEST ACTION
2017-12-14
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ZOLEDRONIC ACIDPrescription
ZOLEDRONIC ACID EQ 5MG BASE/100ML · INJECTABLE · INTRAVENOUS

Approval history

2017-12-14Labeling · Supplement 1 · standardAP
2014-08-21Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →